What Researchers Did
Researchers reported a case of a 62-year-old male with radiation-induced macular ischemia treated with hyperbaric oxygen therapy.
What They Found
They found that a patient's vision improved from 20/400 to 20/100 and central macular thickness from 468 µm to 132 µm after focal laser and intravitreal triamcinolone. Following hyperbaric oxygen therapy, the patient's visual acuity further improved to 20/50, and fluorescein angiography showed improved macular perfusion.
What This Means for Canadian Patients
Hyperbaric oxygen therapy may offer a potential treatment option for Canadian patients experiencing vision loss due to radiation-induced macular ischemia. This therapy could help improve visual acuity and macular perfusion in such cases.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The primary limitation of this study is that it reports only a single case, limiting the generalizability of the findings.